4.8 Article

Label-free detection of C-Reactive protein using bioresponsive hydrogel-based surface relief diffraction gratings

期刊

BIOSENSORS & BIOELECTRONICS
卷 193, 期 -, 页码 -

出版社

ELSEVIER ADVANCED TECHNOLOGY
DOI: 10.1016/j.bios.2021.113561

关键词

Biosensor; Diffraction; Label-free; Surface relief gratings; Responsive hydrogel; C-Reactive protein

资金

  1. E.U. FEDER
  2. Spanish Ministry of Economy and Competitiveness MINECO [BiHolog-CTQ2016-75749-R, AdBiHol-PID2019-110713RB-I00]
  3. Generalitat Valenciana [PROMETEO/2020/094]
  4. MINECO [FJCI-2016-29593, IJC 2018-035355-I]

向作者/读者索取更多资源

A biosensing system based on bioresponsive hydrogels for selective detection of C-Reactive protein (CRP) has been developed, utilizing Direct Laser Interference Patterning to create micro-gratings on the hydrogel substrates. The system achieved detection and quantification limits in human serum dilutions, showing potential for applications related to cardiovascular diseases and sepsis. Further amplification strategies improved sensitivity, widened the linear range, and enhanced limits of detection and quantification.
Responsive hydrogel-based surface relief gratings have demonstrated great performances as transducers in optical sensing. However, novel and smart designs of hydrogels are needed for the appropriate detection of analytes and biomolecules since the existing materials are very limited to specific molecules. In this work, a biosensing system based on surface relief gratings made of bioresponsive hydrogels has been developed. In particular, the hydrogel contains phosphocholine moieties to specifically recognize C-Reactive protein (CRP). The CRP-Sensing hydrogel capacity to selectively detect CRP was fully demonstrated. Using Direct Laser Interference Patterning, micro-gratings were created on CRP-Sensing hydrogel substrates and applied for the label-free sensing of CRP using a simple laser-based homemade optical setup. Limits of detection (LOD) and quantification (LOQ) in human serum dilutions of 1.07 and 8.92 mg L-1, respectively, were reached. These results demonstrate that the biosensing system allows the selective label-free detection of CRP within concentration ranges around those related to risks of cardiovascular diseases and sepsis. Besides, amplification strategies have been carried out improving the sensitivity, widening the linear range, and reaching better LOD and LOQ (0.30 mg L-1 and 4.36 mg L-1). Finally, all the approaches were tested for the quantification of CRP in certified human serum with recoveries of around 100%.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据